Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)
Centro singular
University of Adelaide
Adelaida, AustraliaPublicacións en colaboración con investigadores/as de University of Adelaide (6)
2024
-
A translational framework to DELIVER nanomedicines to the clinic
Nature Nanotechnology
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
-
Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)
Scientific Reports
2019
2018
-
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
Nature Communications, Vol. 9, Núm. 1
-
Germline variation at 8q24 and prostate cancer risk in men of European ancestry
Nature Communications, Vol. 9, Núm. 1